Professor Emilio Perucca
MD, PhD, FRCP (Edin), Chair of Medical Pharmacology, Department on Internal Medicine and Therapeutics and Institute of Neurology C.
Mondino, University of Pavia, Italy.
Professor Perucca is First Vice-President of the International League against Epilepsy (ILAE), Past-President of the Italian League against Epilepsy, and member of the Advisory/Editorial Board of several journals, including Epilepsia, Epileptic Disorders, Epilepsy Research, CNS Drugs, and Seizure. He is a clinical pharmacologist and neurologist with a special interest in the treatment and evaluation of outcome in people with epilepsy.
Contributions to CNSforum by Professor Emilio Perucca:
24.11.2006
Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study
26.10.2006
Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy
27.09.2006
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
24.08.2006
Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial
25.07.2006
Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial
23.06.2006
Rapid detection of major depression in epilepsy: a multicentre st
23.05.2006
Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats
28.04.2006
A Modified Atkins Diet is Effective for the Treatment of Intractable Pediatric Epilepsy
22.03.2006
Seizure control and treatment in pregnancy: Observations from the EURAP Epilepsy in Pregnancy Registry
20.02.2006
Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures
17.01.2006
Pregabalin add-on treatment in patients with partial seizures: A novel evaluation of flexible dose and fixed-dose treatment in a double-blind, placebo-controlled study
22.11.2005
Cerebral damage in epilepsy: A population-based longitudinal quantitative MRI study
23.10.2005
Malformation risks of antiepileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register
21.09.2005
Four-year outcome after early withdrawal of antiepileptic drugs in childhood epilepsy
22.08.2005
Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers
26.07.2005
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: A randomized controlled trial
16.06.2005
New onset geriatric epilepsy. A randomized study of gabapentin, lamotrigine and carbamazepine
22.05.2005
Genetic predictors of the maximum doses patients receive during clinical use of the antiepileptic drugs carbamazepine and phenytoin.
21.04.2005
Lamotrigine and the risk of malformations in pregnancy
22.03.2005
Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy
18.02.2005
Hyperventilation revisited: Physiological effects and efficacy on focal seizure activation in the era of video-EEG monitoring
24.01.2005
Frequency of catamenial seizure exacerbation in women with localization-related epilepsy
22.11.2004
The longer term outcome of children born to mothers with epilepsy
22.10.2004
Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: An open-label, randomized, parallel-group study
22.09.2004
Evaluating the utility of inpatient video-EEG monitoring
23.08.2004
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
28.07.2004
Does glucocorticoid administration prevent late seizures after head injury?
16.06.2004
Randomized controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures
24.05.2004
EEG and ECG in sudden unexplained death in epilepsy
19.04.2004
Encoding of emotional memories depends on amygdala and hippocampus and their interactions.
24.03.2004
The relationship between treatment with valproate, lamotrigine and topiramate and the prognosis of the idiopathic generalized epilepsies
23.02.2004
Pregabalin add-on treatment: A randomised, double-blind, placebo-controlled, dose-response study in adults with partial seizures
28.01.2004
Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy
04.12.2003
Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy
21.11.2003
Postictal serum levels of antiepileptic drugs for detection of noncompliance
27.10.2003
Nicotine as an antiepileptic agent in ADNFLE: An n-of-one study
25.09.2003
Oral contraceptives reduce lamotrigine plasma levels
22.08.2003
Effects of Vagus Nerve Stimulation on Sleep-related Breathing in Epilepsy Patients
29.07.2003
The Spectrum of Long-term Epilepsy-associated Tumors: Long-term Seizure and Tumor Outcome and Neurosurgical Aspects
24.06.2003
The prevalence and treatment gap in epilepsy in China: An ILAE/IBE/WHO study